ReviewBlood science (Baltimore, Md.)2019

Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy.

Huang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.